Comparative analysis of B7‐1 and B7‐2 expression in Langerhans cells: differential regulation by T helper type 1 and T helper type 2 cytokines

Tatsuyoshi Kawamura, Masutaka Furue

Research output: Contribution to journalArticle

106 Citations (Scopus)

Abstract

Epidermal Langerhans cells (LC) are Ia‐bearing potent antigen‐presenting cells (APC) of dendritic cell lineage that play a crucial role in primary and secondary T cell‐dependent immune responses. LC express several costimulatory molecules such as B7, which has been implicated as one of the important determinants of professional APC. Recently, B7 antigens have been shown to include three distinct molecules termed B7‐1, B7‐2, and B7‐3, and the expression of B7‐1 and B7‐2 in LC has been already confirmed. However, little is known of the regulation of B7‐1 and B7‐2 expression in LC. We demonstrated that LC do not express B7‐1 and B7‐2 in situ; however, the expression of both molecules is rapidly induced during the first 3 days of culture, and high levels of expression are maintained at least until day 6. We show that the expression of B7‐2 in LC is much higher than that of B7‐1 in each experiment, and that B7‐1 and B7‐2 expression is reproducibly augmented by interleukin (IL)‐4 in a dose‐dependent manner; however, IL‐2 affected expression very little. Finally, B7‐1 expression is significantly and dose‐dependently down‐regulated by interferon (IFN)‐γ or IL‐10, and B7‐2 expression is consistently inhibited by IL‐10, but not by IFN‐γ. The effects of these cytokines are active only in the induction phase (during first 3 days of culture) of B7 expression: the modulatory effects of cytokines are hardly detected in the plateau phase (days 4 to 6 of culture) of B7 expression in LC. These findings suggest that B7‐1 and B7‐2 expression are indeed selectively and differentially regulated by these T cell‐derived cytokines, and that the cytokines may modulate the synthesis of B7 molecules rather than the degradation of already‐expressed B7 molecules.

Original languageEnglish
Pages (from-to)1913-1917
Number of pages5
JournalEuropean Journal of Immunology
Volume25
Issue number7
DOIs
Publication statusPublished - Jul 1995
Externally publishedYes

Fingerprint

Langerhans Cells
Cytokines
B7 Antigens
Interleukin-10
Interferons
Cell Lineage
Interleukin-4
Dendritic Cells
Interleukin-2
Down-Regulation

All Science Journal Classification (ASJC) codes

  • Immunology and Allergy
  • Immunology

Cite this

@article{141e2dfd3bc8420091bfe44a6de5e36d,
title = "Comparative analysis of B7‐1 and B7‐2 expression in Langerhans cells: differential regulation by T helper type 1 and T helper type 2 cytokines",
abstract = "Epidermal Langerhans cells (LC) are Ia‐bearing potent antigen‐presenting cells (APC) of dendritic cell lineage that play a crucial role in primary and secondary T cell‐dependent immune responses. LC express several costimulatory molecules such as B7, which has been implicated as one of the important determinants of professional APC. Recently, B7 antigens have been shown to include three distinct molecules termed B7‐1, B7‐2, and B7‐3, and the expression of B7‐1 and B7‐2 in LC has been already confirmed. However, little is known of the regulation of B7‐1 and B7‐2 expression in LC. We demonstrated that LC do not express B7‐1 and B7‐2 in situ; however, the expression of both molecules is rapidly induced during the first 3 days of culture, and high levels of expression are maintained at least until day 6. We show that the expression of B7‐2 in LC is much higher than that of B7‐1 in each experiment, and that B7‐1 and B7‐2 expression is reproducibly augmented by interleukin (IL)‐4 in a dose‐dependent manner; however, IL‐2 affected expression very little. Finally, B7‐1 expression is significantly and dose‐dependently down‐regulated by interferon (IFN)‐γ or IL‐10, and B7‐2 expression is consistently inhibited by IL‐10, but not by IFN‐γ. The effects of these cytokines are active only in the induction phase (during first 3 days of culture) of B7 expression: the modulatory effects of cytokines are hardly detected in the plateau phase (days 4 to 6 of culture) of B7 expression in LC. These findings suggest that B7‐1 and B7‐2 expression are indeed selectively and differentially regulated by these T cell‐derived cytokines, and that the cytokines may modulate the synthesis of B7 molecules rather than the degradation of already‐expressed B7 molecules.",
author = "Tatsuyoshi Kawamura and Masutaka Furue",
year = "1995",
month = "7",
doi = "10.1002/eji.1830250718",
language = "English",
volume = "25",
pages = "1913--1917",
journal = "European Journal of Immunology",
issn = "0014-2980",
publisher = "Wiley-VCH Verlag",
number = "7",

}

TY - JOUR

T1 - Comparative analysis of B7‐1 and B7‐2 expression in Langerhans cells

T2 - differential regulation by T helper type 1 and T helper type 2 cytokines

AU - Kawamura, Tatsuyoshi

AU - Furue, Masutaka

PY - 1995/7

Y1 - 1995/7

N2 - Epidermal Langerhans cells (LC) are Ia‐bearing potent antigen‐presenting cells (APC) of dendritic cell lineage that play a crucial role in primary and secondary T cell‐dependent immune responses. LC express several costimulatory molecules such as B7, which has been implicated as one of the important determinants of professional APC. Recently, B7 antigens have been shown to include three distinct molecules termed B7‐1, B7‐2, and B7‐3, and the expression of B7‐1 and B7‐2 in LC has been already confirmed. However, little is known of the regulation of B7‐1 and B7‐2 expression in LC. We demonstrated that LC do not express B7‐1 and B7‐2 in situ; however, the expression of both molecules is rapidly induced during the first 3 days of culture, and high levels of expression are maintained at least until day 6. We show that the expression of B7‐2 in LC is much higher than that of B7‐1 in each experiment, and that B7‐1 and B7‐2 expression is reproducibly augmented by interleukin (IL)‐4 in a dose‐dependent manner; however, IL‐2 affected expression very little. Finally, B7‐1 expression is significantly and dose‐dependently down‐regulated by interferon (IFN)‐γ or IL‐10, and B7‐2 expression is consistently inhibited by IL‐10, but not by IFN‐γ. The effects of these cytokines are active only in the induction phase (during first 3 days of culture) of B7 expression: the modulatory effects of cytokines are hardly detected in the plateau phase (days 4 to 6 of culture) of B7 expression in LC. These findings suggest that B7‐1 and B7‐2 expression are indeed selectively and differentially regulated by these T cell‐derived cytokines, and that the cytokines may modulate the synthesis of B7 molecules rather than the degradation of already‐expressed B7 molecules.

AB - Epidermal Langerhans cells (LC) are Ia‐bearing potent antigen‐presenting cells (APC) of dendritic cell lineage that play a crucial role in primary and secondary T cell‐dependent immune responses. LC express several costimulatory molecules such as B7, which has been implicated as one of the important determinants of professional APC. Recently, B7 antigens have been shown to include three distinct molecules termed B7‐1, B7‐2, and B7‐3, and the expression of B7‐1 and B7‐2 in LC has been already confirmed. However, little is known of the regulation of B7‐1 and B7‐2 expression in LC. We demonstrated that LC do not express B7‐1 and B7‐2 in situ; however, the expression of both molecules is rapidly induced during the first 3 days of culture, and high levels of expression are maintained at least until day 6. We show that the expression of B7‐2 in LC is much higher than that of B7‐1 in each experiment, and that B7‐1 and B7‐2 expression is reproducibly augmented by interleukin (IL)‐4 in a dose‐dependent manner; however, IL‐2 affected expression very little. Finally, B7‐1 expression is significantly and dose‐dependently down‐regulated by interferon (IFN)‐γ or IL‐10, and B7‐2 expression is consistently inhibited by IL‐10, but not by IFN‐γ. The effects of these cytokines are active only in the induction phase (during first 3 days of culture) of B7 expression: the modulatory effects of cytokines are hardly detected in the plateau phase (days 4 to 6 of culture) of B7 expression in LC. These findings suggest that B7‐1 and B7‐2 expression are indeed selectively and differentially regulated by these T cell‐derived cytokines, and that the cytokines may modulate the synthesis of B7 molecules rather than the degradation of already‐expressed B7 molecules.

UR - http://www.scopus.com/inward/record.url?scp=0029034075&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029034075&partnerID=8YFLogxK

U2 - 10.1002/eji.1830250718

DO - 10.1002/eji.1830250718

M3 - Article

C2 - 7542595

AN - SCOPUS:0029034075

VL - 25

SP - 1913

EP - 1917

JO - European Journal of Immunology

JF - European Journal of Immunology

SN - 0014-2980

IS - 7

ER -